Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Jun 2013. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 74237701000001119 | Rivatev | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 74237801000001111 | Rivatev (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 78326201000001115 | Erastig | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivatev | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rivatev 4.6mg/24hours transdermal patches (Teva UK Ltd) | Is a | True | Rivatev | Inferred relationship | Existential restriction modifier | |
| Rivatev 9.5mg/24hours transdermal patches (Teva UK Ltd) | Is a | True | Rivatev | Inferred relationship | Existential restriction modifier | |
| Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) | Is a | True | Rivatev | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR